Profile for NeuroBo Pharmaceuticals Inc. (NRBO)

$ 8.02   -0.56 (-6.53%) Volume: 107.71k 4:00 PM EDT Jul 6, 2020
Business Description:
Gemphire Therapeutics Inc is a clinical-stage biopharmaceutical company developing and commercializing therapies for the treatment of dyslipidemia, a serious medical condition that increases the risk of life threatening cardiovascular disease.
Address: 200 Berkeley Street, Office 19th Floor, Boston, MA, USA, 02116
Telephone: +1 857 702-9600 Website: https://www.neurobopharma.com
Facsimile: N/A Email: [email protected]
Details
CEO: Richard Kang
Employees: 12 Market Cap: 131.75m
Issue Type: CS
Auditor: BDO USA, LLP
Last Audit: Unqualified Opinion with Explanation
Indices: N/A
Industry Classifications
Sector: Healthcare CIK: 1638287
Industry: Biotechnology
Sub-Industry:    Biotechnology
NAICS: Pharmaceutical Preparation Manufacturing (325412)
SIC: Pharmaceutical Preparations (2834)